CLEARTWIST
Live / Registered — Registered (as of 12 Aug 2025)
What this means for you
Registered since 12 Aug 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79408761
- Registration number
- 7885677
- Mark type
- Stylized text
- Filed
- 03 Sept 2024
- Published for opposition
- 24 Jun 2025
- Registered
- 12 Aug 2025
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and medical preparations and medical injection devices for administering drugs sold pre-filled with pharmaceutical preparations, all for the prevention and treatment of renal diseases and disorders, inflammatory diseases and disorders, dermatological diseases and disorders, gastrointestinal diseases and disorders, respiratory diseases and disorders, complement-mediated diseases and disorders, neoplastic diseases and disorders, bone diseases and disorders, diseases and disorders of the immune system, the cardiovascular system, the musculo-skeletal system, the genitourinary system, the central nervous system, the endocrine system, the metabolic system and the circulatory system
Owner
- NOVARTIS AG, CH
- NOVARTIS AG, CH
- NOVARTIS AG, CH
Prosecution history
- 12 Mar 2026 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 25 Feb 2026 — FINAL DISPOSITION NOTICE SENT TO IB
- 25 Feb 2026 — FINAL DISPOSITION PROCESSED
- 12 Nov 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 12 Aug 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 12 Aug 2025 — REGISTERED-PRINCIPAL REGISTER
- 24 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Jun 2025 — PUBLISHED FOR OPPOSITION
- 18 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 May 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 22 May 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 17 May 2025 — REFUSAL PROCESSED BY IB
- 30 Apr 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB